|
11. |
Concepts of Antibody-Mediated Cancer Therapy |
|
Cancer Investigation,
Volume 11,
Issue 2,
1993,
Page 174-184
KummerUdo,
StaerzUwe D.,
Preview
|
PDF (1051KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909309024836
出版商:Taylor&Francis
年代:1993
数据来源: Taylor
|
12. |
Patient Awareness Under General Anesthesia |
|
Cancer Investigation,
Volume 11,
Issue 2,
1993,
Page 185-189
DesiderioDawn P.,
Preview
|
PDF (403KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909309024837
出版商:Taylor&Francis
年代:1993
数据来源: Taylor
|
13. |
Introduction |
|
Cancer Investigation,
Volume 11,
Issue 2,
1993,
Page 190-190
MertelsmannRoland,
HerrmannFriedhelm,
HirshautYashar,
Preview
|
PDF (50KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909309024838
出版商:Taylor&Francis
年代:1993
数据来源: Taylor
|
14. |
Functional Significance of c-myb Expression in Normal and Leukemic Hematopoiesis |
|
Cancer Investigation,
Volume 11,
Issue 2,
1993,
Page 191-197
CalabrettaBruno,
VenturelliDonatella,
GewirtzAlan M.,
Preview
|
PDF (872KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909309024839
出版商:Taylor&Francis
年代:1993
数据来源: Taylor
|
15. |
Modulation of Cytotoxicity and Differentiation-Inducing Potential of Arabinofuranosylcytosine in Myeloid Leukemia Cells by Hematopoietic Cytokines |
|
Cancer Investigation,
Volume 11,
Issue 2,
1993,
Page 198-211
BrachMarion A.,
MertelsmannRoland H.,
HerrmannFriedhelm,
Preview
|
PDF (1175KB)
|
|
摘要:
Hematopoietic growth factors may be useful in improving the clinical effectiveness of arabinofuranosylcytosine (ara-C). In vitro studies have indicated that interleirkin 3 (IL-3) and, to a lesser extent, granulocyte-macrophage colony-stimulating factor (GM-CSF), but not G-CSF or M-CSF, may be capable of specifically augmenting the abiliry of ara-C to kill leukemic myeloid cells by pharamacological and cyto-kinetic mechanisms including increase of intracellular ara-CTP/dCTP pool ratios and enhanced ara-C DNA incorporation in leukemic blast cells, decrease of IC 90 of ara-C for leukemic colony-forming cells (CFC) as compared with normal CFC growth, and recruitment of quiescent leukemic cells into the cell cycle. In contrast, the combination of ara-C with M-CSF or with the leukemia inhibitory factor (LIF) appears to be useful in overcoming the block in differentiation of leukemic blast, while the effects of GM-CSF and IL-3 on ara-C-induced differentiation appear limited. The combined treatment of human myeloid leukemia cells by ara-C and LIF is associated with down-regulation of c-mycgene expression, transcriptional activation ofjuntfosgene expression, and features of functional differentiation (e.g., the capability to reduce nitroblue tetrazolium, to express lysozyme, or to display differentiation-related surface receptors including C3bi and thec-fmsprotein). On the basis of these in vitro studies first clinical trials are underway that are examining the efficacy of ara-C combinations with these molecules for the treatment of myeloid disorders.
ISSN:0735-7907
DOI:10.3109/07357909309024840
出版商:Taylor&Francis
年代:1993
数据来源: Taylor
|
16. |
Clinical Results with Recombinant Human Interleukin-3 |
|
Cancer Investigation,
Volume 11,
Issue 2,
1993,
Page 212-218
GanserArnold,
Preview
|
PDF (592KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909309024841
出版商:Taylor&Francis
年代:1993
数据来源: Taylor
|
17. |
Cyclic Neutropenia: Natural History and Effects of Long-Term Treatment with Recombinant Human Granulocyte Colony-Stimulating Factor |
|
Cancer Investigation,
Volume 11,
Issue 2,
1993,
Page 219-223
DaleDavid C.,
BolyardAudrey Anna,
HammondWilliam P.,
Preview
|
PDF (376KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909309024842
出版商:Taylor&Francis
年代:1993
数据来源: Taylor
|
18. |
The Use of Recombinant Human Granulocyte Macrophage Colony-Stimulating Factor in Autologous and Allogeneic Bone Marrow Transplantation |
|
Cancer Investigation,
Volume 11,
Issue 2,
1993,
Page 224-228
NemunaitisJ.,
SingerJ. W.,
Preview
|
PDF (376KB)
|
|
摘要:
In order to determine the effect of recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF), it has been administered to patients undergoing autologous or allogeneic bone marrow transplant (BMT). Results in patients undergoing antologous or allogeneic BMT indicate that rhGM-CSF is minimally toxic and is associated with reduced morbidity. Trials also indicate that rhGM-CSF may be an acceptable therapy for patients with marrow graft failure since survival appears to improve substantially in patients who received rhGM-CSF compared with historical control patients.
ISSN:0735-7907
DOI:10.3109/07357909309024843
出版商:Taylor&Francis
年代:1993
数据来源: Taylor
|
19. |
Combination Treatment of Acute Myeloblastic Leukemia with rhGM-CSF and Standard Induction Chemotherapy |
|
Cancer Investigation,
Volume 11,
Issue 2,
1993,
Page 229-234
ValentP.,
SillaberCh.,
GeisslerK.,
AndreeffM.,
TafuriA.,
ViederL.,
SchulzG.,
LechnerK.,
BettelheimP.,
Preview
|
PDF (372KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909309024844
出版商:Taylor&Francis
年代:1993
数据来源: Taylor
|
20. |
A Model for Others: A Strategy for Improving Diagnosis and Therapy of Human Malignancies Using Monoclonal Antibodies Targeting TAG72 Oncofetal Antigen |
|
Cancer Investigation,
Volume 11,
Issue 2,
1993,
Page 235-238
LarsonSteven M.,
Preview
|
PDF (296KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909309024845
出版商:Taylor&Francis
年代:1993
数据来源: Taylor
|
|